Piramal Pharma rises on getting EIR with VAI for USA manufacturing facility
Piramal Pharma is currently trading at Rs. 146.85, up by 0.75 points or 0.51% from its previous closing of Rs. 146.10 on the BSE.
The scrip opened at Rs. 144.15 and has touched a high and low of Rs. 147.45 and Rs. 140.85 respectively. So far 136144 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 228.45 on 23-Apr-2025 and a 52 week low of Rs. 132.50 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 147.45 and Rs. 137.30 respectively. The current market cap of the company is Rs. 19559.89 crore.
The promoters holding in the company stood at 34.86%, while Institutions and Non-Institutions held 45.35% and 19.79% respectively.
Piramal Pharma has received Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) from U.S. Food and Drug Administration (USFDA) for its manufacturing facility located at Lexington, (Kentucky, USA). The receipt of said EIR marks successful closure of the inspection.
